Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 3/20 | 0.61 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1487886 | 0.78 | CES1 (0.65) | CES1SRCKCNN4TSHRTDP1 | |
| Water SCHEMBL8542684 | 0.76 | CES1 (0.62) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL1679763 | 0.76 | CES1 (1.00) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL18259095 | 0.76 | CES1 (0.52) | CES1SRCKCNN4TSHRALDH1A1 | |
| SCHEMBL10800215 | 0.76 | CES1 (0.67) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL15173 | 0.76 | CES1 (1.00) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL3661644 | 0.75 | CES1 (0.60) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL10090157 | 0.75 | CES1 (0.60) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL8332006 | 0.75 | CES1 (0.60) | CES1SRCKCNN4TSHRTDP1 | |
| SCHEMBL277653 | 0.74 | CES1 (0.65) | CES1SRCKCNN4TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170241998-A1 | METHOD FOR THE IMMOBILIZATION OF BIOMOLECULES | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170241998-A1 | METHOD FOR THE IMMOBILIZATION OF BIOMOLECULES | PTMS, BTD, SPR | CES1 2756/4885SRC 2070/4885KCNN4 4486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.